Article Information
History
- July 31, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ioanna Nikitopoulou1,#,
- Dionysios Fanidis2,#,
- Konstantinos Ntatsoulis2,#,
- Panagiotis Moulos3,
- George Mpekoulis4,
- Maria Evangelidou5,
- Alice G. Vassiliou1,
- Vasiliki Dimakopoulou6,
- Edison Jahaj7,
- Stamatios Tsipilis7,
- Stylianos E. Orfanos7,
- Ioanna Dimopoulou7,
- Emmanouil Angelakis5,
- Karolina Akinosoglou6,
- Niki Vassilaki4,
- Argyris Tzouvelekis6,
- Anastasia Kotanidou1,7 and
- Vassilis Aidinis2,*
- 1GP Livanos and M Simou Laboratories, National & Kapodistrian University of Athens, Evangelismos General Hospital, Athens, Greece
- 2Institute of Bio-Innovation, Biomedical Sciences Research Center Alexander Fleming, Athens 16672, Greece
- 3Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center Alexander Fleming, Athens 16672, Greece
- 4Molecular Virology Laboratory, Hellenic Pasteur Institute, Athens 11521, Greece
- 5Department of Diagnostics, Hellenic Pasteur Institute, Athens 11521, Greece
- 6Department of Respiratory Medicine, University Hospital of Patras, Patras 26504, Greece
- 71st Department of Critical Care & Pulmonary Services, Medical School, National & Kapodistrian University of Athens, Evangelismos General Hospital, Athens, Greece
- ↵*Correspondence should be addressed to V.Aidinis{at}Fleming.gr
↵# Equal contribution
Posted July 31, 2021.
Increased Autotaxin levels in severe COVID-19, correlating with IL-6 levels, endothelial dysfunction biomarkers, and impaired functions of dendritic cells
